Published in Dis Colon Rectum on March 01, 1994
Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg (2003) 1.65
Functional results and visceral perception after ileo neo-rectal anastomosis in patients: a pilot study. Gut (2001) 1.40
Is age relevant to functional outcome after restorative proctocolectomy for ulcerative colitis?: prospective assessment of 122 cases. Ann Surg (1998) 0.96
Evaluation of vector manometry for characterization of functional outcome after restorative proctocolectomy. Int J Colorectal Dis (2008) 0.79
Pouchitis and pre-pouch ileitis developed after restorative proctocolectomy for ulcerative colitis: a case report. World J Gastroenterol (2007) 0.76
Biofeedback versus electrostimulation in treatment of anal sphincter insufficiency. Dig Dis Sci (2003) 0.76
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Etiology and management of fecal incontinence. Dis Colon Rectum (1993) 7.68
BioJava: an open-source framework for bioinformatics. Bioinformatics (2008) 6.17
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62
Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum (2000) 5.07
Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum (1999) 4.20
Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg (1996) 3.76
A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum (1996) 2.87
Practice parameters for the treatment of sigmoid diverticulitis--supporting documentation. The Standards Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum (2000) 2.77
Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75
Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet (1988) 2.48
Trocar site recurrence in laparoscopic surgery for colorectal cancer. Surg Endosc (2001) 2.47
BCG immunotherapy of bladder cancer: 20 years on. Lancet (1999) 2.38
Starch and intraperitoneal adhesion formation. Br J Surg (1973) 2.30
Human monoclonal antibody production. Current status and future prospects. J Immunol Methods (1987) 2.21
Factors predictive of outcome after surgery for faecal incontinence. Br J Surg (2000) 2.15
Laboratory staff qualifications and accuracy of proficiency test results. A national study. Arch Pathol Lab Med (1992) 2.07
The natural history of Peyronie's disease. J Urol (1990) 2.02
Laparoscopic resection of colon Cancer: consensus of the European Association of Endoscopic Surgery (EAES). Surg Endosc (2004) 2.01
Is obesity a high-risk factor for laparoscopic colorectal surgery? Surg Endosc (2002) 1.95
Long-term follow-up of patients undergoing colectomy for colonic inertia. Dis Colon Rectum (2001) 1.90
Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro. Nature (1967) 1.89
Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum (1990) 1.85
Psychotic men remanded in custody to Brixton Prison. Br J Psychiatry (1994) 1.77
Prospective, randomized, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods. Dis Colon Rectum (1994) 1.76
Mechanical bowel preparation for elective colorectal surgery. A prospective, randomized, surgeon-blinded trial comparing sodium phosphate and polyethylene glycol-based oral lavage solutions. Dis Colon Rectum (1997) 1.75
Internal fistulas in diverticular disease. Dis Colon Rectum (1988) 1.75
Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.72
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70
Laparoscopic resection rectopexy versus laparoscopic ventral rectopexy for complete rectal prolapse. Tech Coloproctol (2014) 1.68
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol (1990) 1.66
Laparoscopic surgery for diverticulitis. Surg Endosc (1997) 1.64
Evaluation and surgical treatment of rectal prolapse: an international survey. Colorectal Dis (2013) 1.64
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol (1999) 1.63
Recurrence and reoperation for Crohn's disease: the role of disease location in prognosis. N Engl J Med (1981) 1.60
Is early oral feeding safe after elective colorectal surgery? A prospective randomized trial. Ann Surg (1995) 1.60
Anal manometric predictors of significant rectocele in constipated patients. Tech Coloproctol (2002) 1.59
A genomewide suppressor and enhancer analysis of cdc13-1 reveals varied cellular processes influencing telomere capping in Saccharomyces cerevisiae. Genetics (2008) 1.58
Prospective assessment of biofeedback for the treatment of paradoxical puborectalis contraction. Dis Colon Rectum (1992) 1.55
The surgical management of anorectal diseases in AIDS and pre-AIDS patients. Dis Colon Rectum (1986) 1.53
Some factors influencing the ability of anti-lymphocytic antibody to suppress humoral antibody formation. Clin Exp Immunol (1967) 1.52
Principles of privileging and credentialing for endoscopy and colonoscopy. Surg Endosc (2002) 1.52
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol (2002) 1.50
Laparoscopic colectomy: a critical appraisal. Dis Colon Rectum (1993) 1.50
Consensus conference on the stapled transanal rectal resection (STARR) for disordered defaecation. Colorectal Dis (2006) 1.49
Laparoscopic total mesorectal excision. Surg Endosc (2002) 1.49
Associations of defecography and physiologic findings in male patients with rectocele. Tech Coloproctol (2001) 1.49
The preparation and properties of anti-lymphocytic sera. Prog Surg (1969) 1.48
Patient evaluation of the conventional ileostomy. Dis Colon Rectum (1985) 1.46
[Surgical treatment of the single non traumatic perforation of small bowel: excision-suture or resection-anastomosis]. Ann Chir (2005) 1.45
Catheter drainage of ischiorectal abscesses. South Med J (1988) 1.44
Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol (2000) 1.43
Structure-property correlations in a combinatorial library of degradable biomaterials. J Biomed Mater Res (1998) 1.42
Continuous thoracic epidural analgesia versus combined spinal/thoracic epidural analgesia on pain, pulmonary function and the metabolic response following colonic resection. Acta Anaesthesiol Scand (1996) 1.42
Gastroduodenal polyps in patients with familial adenomatous polyposis. Dis Colon Rectum (1992) 1.41
Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats. Lancet (1967) 1.41
Desmoid tumors in familial polyposis coli. Ann Surg (1986) 1.41
Effect of anti-rat lymphocyte antibody on humoral antibody formation. Nature (1967) 1.40
Ileal pouch anal function after endoanal mucosectomy and handsewn ileoanal anastomosis versus stapled anastomosis without mucosectomy. Eur J Surg (1995) 1.38
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol (1992) 1.38
Radiation injury of the rectum: evaluation of surgical treatment. Ann Surg (1981) 1.37
Loop ileostomy is a safe option for fecal diversion. Dis Colon Rectum (1993) 1.35
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1996) 1.32
Villous tumors of the duodenum. Ann Surg (1988) 1.31
The use of transanal rectal advancement flaps in the management of fistulas involving the anorectum. Dis Colon Rectum (1987) 1.31
Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum (1992) 1.31
Laparoscopic colorectal surgery. Do we get faster? Surg Endosc (1997) 1.29
Intraoperative laparoscopic complications. Are we getting better? Dis Colon Rectum (1996) 1.28
Characterization of antilymphocytic antibody. Nature (1967) 1.27
Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma. J Clin Oncol (1998) 1.27
Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg (1993) 1.26
Randomized comparison of straight and colonic J pouch anastomosis after low anterior resection. Ann Surg (1996) 1.26
The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1. Clin Exp Immunol (1983) 1.25
Does laparoscopic-assisted ileal pouch anal anastomosis reduce the length of hospitalization? Int J Colorectal Dis (1994) 1.24
Laparoscopic surgery in the management of inflammatory bowel disease. Am J Surg (1996) 1.24
Laparoscopic total abdominal colectomy. A prospective trial. Dis Colon Rectum (1992) 1.24
Ileorectal anastomosis: appreciation by patients. Br Med J (1969) 1.24
Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels produced in Ireland. Toxicon (2000) 1.23
Must early postoperative oral intake be limited to laparoscopy? Dis Colon Rectum (1994) 1.23
Reproducibility of colonic transit study in patients with chronic constipation. Dis Colon Rectum (2001) 1.22
Postoperative perineal hernia. Dis Colon Rectum (1987) 1.22